Data
Lookout
Search
Browse
Diseases
Sponsors
Pipeline Pulse
Weekly Report
Watchlist
Blog
Pricing
Sign In
Home
NCT07754279
Clinical Trial
Clinical Trial of the Safety and Tolerability of MMH-522 in Healthy Volunteers
Completed
Phase 1
View on ClinicalTrials.gov →
Summary
Open-label, non-comparative, non-randomized clinical trial of the safety and tolerability of the drug MMH-450 in healthy volunteers consisting of 4 consecutive stages
Trial Details
NCT Number
NCT07754279
Lead Sponsor
Materia Medica Holding
Conditions
Cough
Enrollment
16 participants
Start Date
2026-02-12
Primary Completion
2026-04-16
(estimated)
Study Completion
2026-05-07
(estimated)
Updated on ClinicalTrials.gov
2026-08-10